Clayton, Dubilier & Rice, LLC as manager of CD&R Funds X and XI)
to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014
On
12 May 2021, the boards of Nenelite Limited ( Bidco ) and UDG Healthcare plc ( UDG ) announced that they had reached agreement on the terms of a cash offer, unanimously recommended by the board of UDG, pursuant to which Bidco, an Affiliate of Clayton, Dubilier & Rice, LLC ( CD&R ), will acquire the entire issued and to be issued share capital of UDG (the Acquisition ).
The Acquisition is to be effected by way of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 (the Scheme ).
Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES
FOR IMMEDIATE RELEASE
Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipeline with Multiple Near-term Inflection Points
Diversifies Revenue Base with Two Rapidly Growing Brands in Xeris Gvoke® and Strongbridge s KEVEYIS®
Tel: + 353-1-468-9000 The directors of UDG ( UDG Directors ) accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the UDG Directors (who have taken all reasonable care to ensure such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information. This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside Ireland or the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the re
The Directors of Glanbia plc (the Company ) are pleased to announce that all the resolutions put to its Annual General Meeting ( AGM ) held earlier today, Thursday 6 May 2021, were duly passed on a poll. The full text of each resolution was included in the Notice of the AGM of the Company published on the Company s website www.glanbia.com on 22 March 2021 and, where requested, were posted to shareholders on 29 March 2021. In accordance with the Listing Rules copies of the resolutions passed at the AGM of the Company have been forwarded to both Euronext Dublin and the UK National Storage Mechanism and will shortly be available for inspection at the following locations:-
Aon Plc - Rule 2.10 Announcement
PR Newswire
Aon plc - Rule 2.10 Announcement - Relevant Securities in Issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
LONDON, U.K, May 4, 2021 In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, Aon plc ( Aon ) confirms that, as of the close of business on April 30, 2021, Aon s issued share capital, excluding treasury shares, consisted of 225,630,496 Class A ordinary shares, $0.01 nominal value per share ( Aon Shares ). Aon Shares are traded on the NYSE under the symbol AON. The International Securities Identification Number (ISIN) of the Aon Shares is IE00BLP1HW54.